Showing 1,528 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

HIV treatment for children & young people

Pharmaceutical corporations are failing children with HIV

Editor's pick
Médecins Sans Frontières (MSF)
30 November 2018
Access to healthcare

Trump Wants to Restrict Access to HIV Meds for People on Medicare

Editor's pick
Poz
29 November 2018
HIV treatment for children & young people

MSF: Pharmaceutical corporations failing children with HIV

Editor's pick
Doctors Without Borders
29 November 2018
Generic medicines

Gilead investors spooked by UnitedHealthcare push to cut HIV drug costs

Editor's pick
FiercePharma
5 November 2018
Pharmaceutical industry

Gilead's HIV portfolio soars, but is it enough to combat falling HCV sales?

Editor's pick
FiercePharma
29 October 2018
Pharmaceutical industry

Patients 'may need to stockpile own drugs if no-deal Brexit looms'

Editor's pick
The Guardian
23 October 2018
Drug-resistant TB

Johnson & Johnson prices keep key TB medicines out of reach

Editor's pick
MSF
23 October 2018
The search for a cure

Gilead and Aelix join forces to pursue HIV 'cure'

Editor's pick
PMLiVE
18 October 2018
Access to healthcare

The health innovation system is ‘broken’ and failing patients

Editor's pick
STOP AIDS
18 October 2018
Access to healthcare

Impatient patients turn to online 'buyers club' for new drugs

Editor's pick
Reuters
3 October 2018
Pharmaceutical industry

Fears over HIV drugs in event of ‘no deal’ Brexit

Editor's pick
Gay Star News
2 October 2018
Pharmaceutical industry

What It Means for Gilead to Launch Its Own Generics for Hepatitis C Treatments

Editor's pick
24/7 Wall St.
25 September 2018
Pharmaceutical industry

Gilead to launch generic versions of its hepatitis drugs

Editor's pick
Reuters
25 September 2018
Access to healthcare

Brazil court strips Gilead hepatitis drug patent, politician says

Editor's pick
Reuters
25 September 2018
New & experimental HIV treatments

European advisory group backs Merck's HIV meds Delstrigo and Pifeltro

Editor's pick
Seeking Alpha
24 September 2018
PrEP

PrEP drug patent overturned in UK - NAT respond

Editor's pick
National AIDS Trust
18 September 2018
Finance & funding

A Crazy, Murky System for Pricing HIV Drugs

Editor's pick
New York Times
18 September 2018
Pharmaceutical industry

EPO Upholds Gilead Patent On Hep C Medicines, But In Amended Form

Editor's pick
Intellectual Property Watch
16 September 2018
Pharmaceutical industry

Groups Call for End to Gilead’s Unwarranted Hepatitis C Drug Monopoly in Europe

Editor's pick
MSF press release
11 September 2018
Pharmaceutical industry

CJEU Ruling on Truvada recalls ‘evergreening’ goes against public health interests

Editor's pick
Medicines Law & Policy
10 September 2018
Pharmaceutical industry

Chasing top HIV players, Merck scores FDA approval for 2 new drugs

Editor's pick
FiercePharma
1 September 2018
New & experimental HIV treatments

Should Gilead Be Worried About This New Monthly HIV Medication?

Editor's pick
Motley Fool
16 August 2018
Pharmaceutical industry

Gilead Said PrEP To Prevent HIV Was 'Not A Commercial Opportunity.' Now It's Running Ads For It

Editor's pick
Forbes Magazine
7 August 2018
Pharmaceutical industry

Mylan, lambasted for EpiPen price hikes, complains of overpriced anti-HIV drugs in the United States

Editor's pick
Science
7 August 2018